Testosterone Therapy in Men with Low‑Normal Testosterone

This document provides a professional, evidence‑based overview of the role of testosterone replacement therapy (TRT) in men who present with symptoms of androgen deficiency but whose testosterone levels fall within the low‑normal reference range. It is intended for patient education and for distribution to healthcare collaborators or website developers.

Background

Men frequently report symptoms such as fatigue, reduced libido, diminished exercise tolerance, low mood, and reduced vitality, yet have testosterone concentrations reported as low‑normal. This represents a recognised clinical grey zone. Symptoms alone are non‑specific, and testosterone levels are influenced by circadian rhythm, acute illness, sleep quality, body composition, medications, alcohol intake, and chronic disease.

Evidence Summary

Randomised controlled trials and guideline reviews demonstrate that testosterone therapy provides the most consistent benefit for sexual symptoms, particularly libido and sexual activity, in men with confirmed low testosterone. Improvements in energy, mood, and physical performance are variable and, on average, modest.

Large contemporary safety trials, including cardiovascular outcome studies, indicate that testosterone therapy is not associated with an increased rate of major adverse cardiovascular events when prescribed to appropriately selected men and monitored correctly. However, certain adverse effects such as erythrocytosis and atrial arrhythmias reinforce the importance of careful patient selection and ongoing monitoring.

Common Causes of Low‑Normal Testosterone

The most common causes in middle‑aged and older men are functional and potentially reversible. These include excess adiposity and insulin resistance, obstructive sleep apnoea, chronic stress, alcohol excess, medications (particularly opioids and glucocorticoids), systemic illness, and under‑nutrition or over‑training. Primary testicular failure and pituitary disorders are less common but must be excluded when clinically indicated.

Assessment Approach

Best practice requires confirmation of testosterone levels with at least two early‑morning measurements, preferably fasting. In borderline cases, sex hormone‑binding globulin and calculated free testosterone are useful adjuncts. Assessment should include evaluation for reversible contributors and targeted endocrine investigations where appropriate.

When Testosterone Therapy May Be Considered

A carefully monitored trial of testosterone therapy may be reasonable in men who have consistent symptoms, repeatedly low or borderline testosterone levels, and no untreated contraindications, after reversible factors have been addressed. The therapeutic goal is restoration to the mid‑normal physiological range, not supraphysiological dosing.

Important Considerations

Exogenous testosterone suppresses endogenous gonadotropin secretion and may impair spermatogenesis. Men wishing to preserve fertility should not commence testosterone therapy without specialist discussion of alternatives. Regular monitoring of clinical response and safety parameters is essential.

Conclusion

Low‑normal testosterone is common and does not automatically indicate a need for testosterone therapy. A structured, evidence‑based assessment allows identification of men most likely to benefit while minimising risk. When used appropriately, testosterone therapy can be an effective component of comprehensive endocrine care.